Venus Remedies Ltd (VENUSREM)
₹385.8▲4.27%
Performance
Day's Low
Day's High
₹368.2₹387.252 Week's Low
52 Week's High
₹222₹430
| Returns % | |
| 1 Month Return | -3.17 % |
| 3 Month Return | + 12.22 % |
| 1 Year Return | + 34.4 % |
| Market Stats | |
| Previous Close | ₹370.00 |
| Open | ₹368.20 |
| Volume | 39.60K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹494.58Cr |
Key Statistics
| P/E Ratio | 17.36 |
| PEG Ratio | 12.14 |
| Market Cap | ₹494.58 Cr |
| P/B Ratio | 0.45 |
| EPS | 0 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹494.58 Cr | 274.82% | 0.55 | ₹26 Cr | ₹555 Cr |
 | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
| NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
 | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
| NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Company Information
Share Price: ₹385.80 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹494.58Cr as of today
Revenue: ₹195.16Cr as on March 2024 (Q1 24)
Net Profit: ₹10.51Cr as on March 2024 (Q1 24)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
| Organisation | Venus Remedies Ltd |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Venus Remedies Ltd
Venus Remedies Implements QR Codes for Batch-Level Tracking - 17 Jul, 2024
Venus Remedies has implemented QR codes on all their products in India, allowing for batch-level tracking and detailed product information. The company plans to extend this feature to the domestic market in the coming years.
Venus Remedies Awarded Tender for Cancer Drugs Supply - 19 Jun, 2024
Venus Remedies receives a significant oncology tender from the Pan American Health Organization (PAHO) to supply essential cancer drugs, leading to a surge in share prices. The contract highlights the company's growing presence in the oncology sector and its capability to meet international healthcare standards.
Insights on Venus Remedies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 56.61% to 57.03% in Jun 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 145.77 Cr → 199.08 Cr (in ₹), with an average increase of 26.8% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 6.85 Cr → 10.51 Cr (in ₹), with an average increase of 34.8% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 52.8%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 145.0%
NEGATIVE IMPACTPrice Dip
In the last 3 years, VENUSREM stock has moved down by -17.3%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 1.48% to 1.06% in Jun 2024 quarter
Company Financials
| Q'1 24 | Q/Q Change | |
|---|---|---|
Revenue | ₹195.16Cr | ↑36.08% |
Net Income | ₹10.51Cr | ↑53.43% |
Net Profit Margin | 5.39% | ↑12.76% |
| 2023 | Y/Y Change | |
|---|---|---|
Revenue | ₹555.51Cr | ↓7.44% |
Net Income | ₹26.57Cr | ↓34.75% |
Net Profit Margin | 4.78% | ↓29.50% |
| 2023 | Y/Y Change | |
|---|---|---|
Total Assets | ₹641.67Cr | ↑4.94% |
Total Liabilities | ₹163.62Cr | ↑0.98% |
| 2023 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | ₹28.05Cr | ↓31.59% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 41.76% | 0.00 | |
| Foreign Institutions | 1.06% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 57.03% | 0.73 | |
| Others | 0.15% | 0.00 |
Key Indicators
Venus Remedies Ltd Valuation
Venus Remedies Ltd in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (17.36x)
July 23, 2024
Industry (56.07x)
July 23, 2024
Highest (21.70x)
December 28, 2023
Earnings and Dividends
Venus Remedies Ltd Earnings Results
Venus Remedies Ltd’s net profit fell -4.97% since last year same period to ₹10.51Cr in the Q4 2023-2024. On a quarterly growth basis, Venus Remedies Ltd has generated 53.43% jump in its net profits since last 3-months.
Read More about Earnings ResultsVenus Remedies Ltd Dividends May,2013
In the quarter ending March 2013, Venus Remedies Ltd has declared dividend of ₹3 - translating a dividend yield of 1.56%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Venus Remedies Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Venus Remedies Ltd shares.
Venus Remedies Ltd (VENUSREM) share price today is ₹385.8
Venus Remedies Ltd is listed on NSE
Venus Remedies Ltd is listed on BSE
- Today’s highest price of Venus Remedies Ltd is ₹387.2.
- Today’s lowest price of Venus Remedies Ltd is ₹368.2.
PE Ratio of Venus Remedies Ltd is 17.36
PE ratio = Venus Remedies Ltd Market price per share / Venus Remedies Ltd Earnings per share
Today’s traded volume of Venus Remedies Ltd(VENUSREM) is 39.60K.
Today’s market capitalisation of Venus Remedies Ltd(VENUSREM) is ₹494.58Cr.
| Venus Remedies Ltd(VENUSREM | Price |
|---|---|
52 Week High | ₹430 |
52 Week Low | ₹222 |
Venus Remedies Ltd(VENUSREM) share price is ₹385.8. It is down -10.28% from its 52 Week High price of ₹430
Venus Remedies Ltd(VENUSREM) share price is ₹385.8. It is up 73.78% from its 52 Week Low price of ₹222
| Venus Remedies Ltd(VENUSREM | Returns |
|---|---|
1 Day Returns | 15.8% |
1 Month Returns | -3.17% |
3 Month Returns | 12.22% |
1 Year Returns | 34.4% |